173 related articles for article (PubMed ID: 34723952)
1. Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis.
Sirois I; Isabelle M; Duquette JD; Saab F; Caron E
J Vis Exp; 2021 Oct; (176):. PubMed ID: 34723952
[TBL] [Abstract][Full Text] [Related]
2. In Immunopeptidomics We Need a Sniper Instead of a Shotgun.
Faridi P; Purcell AW; Croft NP
Proteomics; 2018 Jun; 18(12):e1700464. PubMed ID: 29377634
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry.
Caron E; Kowalewski DJ; Chiek Koh C; Sturm T; Schuster H; Aebersold R
Mol Cell Proteomics; 2015 Dec; 14(12):3105-17. PubMed ID: 26628741
[TBL] [Abstract][Full Text] [Related]
4. Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery.
Stutzmann C; Peng J; Wu Z; Savoie C; Sirois I; Thibault P; Wheeler AR; Caron E
Cell Rep Methods; 2023 Jun; 3(6):100511. PubMed ID: 37426761
[TBL] [Abstract][Full Text] [Related]
5. Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery.
Zhang B; Bassani-Sternberg M
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37899131
[TBL] [Abstract][Full Text] [Related]
6. Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows.
Partridge T; Nicastri A; Kliszczak AE; Yindom LM; Kessler BM; Ternette N; Borrow P
Front Immunol; 2018; 9():912. PubMed ID: 29780384
[TBL] [Abstract][Full Text] [Related]
7. Mass Spectrometry Based Immunopeptidomics for the Discovery of Cancer Neoantigens.
Bassani-Sternberg M
Methods Mol Biol; 2018; 1719():209-221. PubMed ID: 29476514
[TBL] [Abstract][Full Text] [Related]
8. Precision Neoantigen Discovery Using Large-Scale Immunopeptidomes and Composite Modeling of MHC Peptide Presentation.
Pyke RM; Mellacheruvu D; Dea S; Abbott C; Zhang SV; Phillips NA; Harris J; Bartha G; Desai S; McClory R; West J; Snyder MP; Chen R; Boyle SM
Mol Cell Proteomics; 2023 Apr; 22(4):100506. PubMed ID: 36796642
[TBL] [Abstract][Full Text] [Related]
9. TOF
Hoenisch Gravel N; Nelde A; Bauer J; Mühlenbruch L; Schroeder SM; Neidert MC; Scheid J; Lemke S; Dubbelaar ML; Wacker M; Dengler A; Klein R; Mauz PS; Löwenheim H; Hauri-Hohl M; Martin R; Hennenlotter J; Stenzl A; Heitmann JS; Salih HR; Rammensee HG; Walz JS
Nat Commun; 2023 Nov; 14(1):7472. PubMed ID: 37978195
[TBL] [Abstract][Full Text] [Related]
10. Mass Spectrometry-Based Immunopeptidomics of Peptides Presented on Human Leukocyte Antigen Proteins.
ElAbd H; Franke A
Methods Mol Biol; 2024; 2758():425-443. PubMed ID: 38549028
[TBL] [Abstract][Full Text] [Related]
11. Purification and Identification of Naturally Presented MHC Class I and II Ligands.
Nelde A; Kowalewski DJ; Stevanović S
Methods Mol Biol; 2019; 1988():123-136. PubMed ID: 31147937
[TBL] [Abstract][Full Text] [Related]
12. SAPrIm, a semi-automated protocol for mid-throughput immunopeptidomics.
Lim Kam Sian TCC; Goncalves G; Steele JR; Shamekhi T; Bramberger L; Jin D; Shahbazy M; Purcell AW; Ramarathinam S; Stoychev S; Faridi P
Front Immunol; 2023; 14():1107576. PubMed ID: 37334365
[TBL] [Abstract][Full Text] [Related]
13. IMBAS-MS Discovers Organ-Specific HLA Peptide Patterns in Plasma.
Wahle M; Thielert M; Zwiebel M; Skowronek P; Zeng WF; Mann M
Mol Cell Proteomics; 2024 Jan; 23(1):100689. PubMed ID: 38043703
[TBL] [Abstract][Full Text] [Related]
14. The impact of immunopeptidomics: From basic research to clinical implementation.
Shapiro IE; Bassani-Sternberg M
Semin Immunol; 2023 Mar; 66():101727. PubMed ID: 36764021
[TBL] [Abstract][Full Text] [Related]
15. Development of a semi-automated MHC-associated peptide proteomics (MAPPs) method using streptavidin bead-based immunoaffinity capture and nano LC-MS/MS to support immunogenicity risk assessment in drug development.
Lee MV; Saad OM; Wong S; LaMar J; Kamen L; Ordonia B; Melendez R; Hassanzadeh A; Chung S; Kaur S
Front Immunol; 2023; 14():1295285. PubMed ID: 38022649
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry-based identification of MHC-bound peptides for immunopeptidomics.
Purcell AW; Ramarathinam SH; Ternette N
Nat Protoc; 2019 Jun; 14(6):1687-1707. PubMed ID: 31092913
[TBL] [Abstract][Full Text] [Related]
17. Benchmarking Bioinformatics Pipelines in Data-Independent Acquisition Mass Spectrometry for Immunopeptidomics.
Shahbazy M; Ramarathinam SH; Illing PT; Jappe EC; Faridi P; Croft NP; Purcell AW
Mol Cell Proteomics; 2023 Apr; 22(4):100515. PubMed ID: 36796644
[TBL] [Abstract][Full Text] [Related]
18. Sensitive, High-Throughput HLA-I and HLA-II Immunopeptidomics Using Parallel Accumulation-Serial Fragmentation Mass Spectrometry.
Phulphagar KM; Ctortecka C; Jacome ASV; Klaeger S; Verzani EK; Hernandez GM; Udeshi ND; Clauser KR; Abelin JG; Carr SA
Mol Cell Proteomics; 2023 Jun; 22(6):100563. PubMed ID: 37142057
[TBL] [Abstract][Full Text] [Related]
19. Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data.
Reynisson B; Barra C; Kaabinejadian S; Hildebrand WH; Peters B; Nielsen M
J Proteome Res; 2020 Jun; 19(6):2304-2315. PubMed ID: 32308001
[TBL] [Abstract][Full Text] [Related]
20. High-Throughput, Fast, and Sensitive Immunopeptidomics Sample Processing for Mass Spectrometry.
Marino F; Chong C; Michaux J; Bassani-Sternberg M
Methods Mol Biol; 2019; 1913():67-79. PubMed ID: 30666599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]